Headquarters:
Ballsbridge
Description:
Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease.
Categories:
Biotechnology
Website:
http://www.amarincorp.com

Company Details

Update
Founded:
1991
Employees:
4 in CrunchBase

Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease. Amarin’s lead candidate, AMR101, is currently being studied in two concurrently run pivotal Phase 3 trials. These trials are investigating the efficacy of AMR101 in lowering triglycerides in patients with very high triglycerides (>500mg/dl) and in patients with mixed dyslipidemia who are taking statins. Amarin’s cardiovascular programs capitalize on Amarin's expertise in the field of lipid science and the known therapeutic benefits of essential fatty acids in treating cardiovascular disease. Amarin is headquartered in Dublin, Ireland, and has its research and development headquartered in Mystic Connecticut, USA. Amarin is listed in the U.S. on NASDAQ (ticker: AMRN)

Current Team (4)

Update

Past Team (1)

Update

Funding Rounds (1) - $70M

Update

Board Members and Advisors (5)

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    First Floor, Block 3, The Oval,

    Shelbourne Road, Dublin 4,

    Ballsbridge,

    IRL

News (1)

Update

    Images (2)

    Update
    • Mgl2yznhnwzcbsd0cab5
    • Mgl2yznhnwzcbsd0cab5